174. Bertelsen A, Hansen O, Brink C. Does VMAT for treatment of NSCLC patients increase the risk of pneumonitis compared to IMRT ? - A planning study. Acta Oncol. 2012 Jan 17.

173. Kaiser FJ, Bassler N, Tölli H, Jäkel O. Initial recombination in the track of heavy charged particles: Numerical solution for air filled ionization chambers. Acta Oncol. 2011 Nov 2.

172. Hansen AE, Kristensen AT, Law I, McEvoy FJ, Kjær A, Engelholm SA. Multimodality functional imaging of spontaneous canine tumors using (64)Cu-ATSM and (18)FDG PET/CT and dynamic contrast enhanced perfusion CT. Radiother Oncol. 2011 Nov 24.

171. Carl J, Nielsen J, Nielsen MS, Zepernick PR, Kjaergaard B, Jensen HK. A new lung stent tested as fiducial marker in a porcine model. Radiother Oncol. 2011 Dec 20.

170. Thomsen JB, Arp DT, Carl J. Urethra sparing - potential of combined Nickel-Titanium stent and intensity modulated radiation therapy in prostate cancer. Radiother Oncol. 2011 Dec 23.

169. Hoffmann L, Jørgensen MB, Muren LP, Petersen JB. Clinical validation of the Acuros XB photon dose calculation algorithm, a grid-based Boltzmann equation solver. Acta Oncol. 2011 Nov 7.

168. Nielsen TB, Hansen VN, Westberg J, Hansen O, Brink C. A dual centre study of setup accuracy for thoracic patients based on Cone-Beam CT data. Radiother Oncol. 2011 Dec 21.

167. Fledelius W, Worm E, Elstro̸m UV, Petersen JB, Grau C, Ho̸yer M, Poulsen PR. Robust automatic segmentation of multiple implanted cylindrical gold fiducial markers in cone-beam CT projections. Med Phys. 2011 Dec;38(12):6351.

166. D'Andrea FP, Horsman MR, Kassem M, Overgaard J, Safwat A. Tumourigenicity and radiation resistance of mesenchymal stem cells. Acta Oncol. 2011 Dec 7.

165. Wojdacz TK, Thestrup BB, Overgaard J, Hansen LL. Methylation of cancer related genes in tumor and peripheral blood DNA from the same breast cancer patient as two independent events. Diagn Pathol. 2011 Nov 30;6(1):116.

164. Wojdacz TK, Thestrup BB, Cold S, Overgaard J, Hansen LL. No difference in the frequency of locus-specific methylation in the peripheral blood DNA of women diagnosed with breast cancer and age-matched controls. Future Oncol. 2011 Dec;7(12):1451-5.

163. Schmitz T, Blaickner M, Ziegner M, Bassler N, Grunewald C, Kratz JV, Schütz C, Langguth P, Sharpe P, Palmans H, Holzscheiter MH, Otto G, Hampel G. Dose determination using alanine detectors in a mixed neutron and gamma field for boron neutron capture therapy of liver malignancies. Acta Oncol. 2011 Aug;50(6):817-22.

162. Hysing LB, Söhn M, Muren LP, Alber M. A coverage probability based method to estimate patient-specific small bowel planning volumes for use in radiotherapy. Radiother Oncol. 2011 Sep;100(3):407-11.

161. Busk M, Bohn AB, Skals M, Wang T, Horsman MR. Combretastatin-induced hypertension and the consequences for its combination with other therapies. Vascul Pharmacol. 2011 Jan-Feb;54(1-2):13-7.

160. Bertelsen LB, Shen YY, Nielsen T, Stødkilde-Jørgensen H, Lloyd GK, Siemann DW, Horsman MR. Vascular effects of plinabulin (NPI-2358) and the influence on tumour response when given alone or combined with radiation. Int J Radiat Biol. 2011 Nov;87(11):1126-34.

159. Waldeland E, Helt-Hansen J, Malinen E Characterization of lithium formate EPR dosimeters for high dose applications – Comparison with alanine Radiation Measurements 46:213-8, 2011.

158. Rosenschöld PM, Engelholm S, Ohlhues L, Law I, Vogelius I, Engelholm SA. Photon and proton therapy planning comparison for malignant glioma based on CT, FDG-PET, DTI-MRI and fiber tracking. Acta Oncol. 2011 Aug;50(6):777-83.

157. Lühr A, Hansen DC, Sobolevsky N, Palmans H, Rossomme S, Bassler N. Fluence correction factors and stopping power ratios for clinical ion beams. Acta Oncol. 2011 Aug;50(6):797-805.

156. Haack S, Jespersen SN, Fokdal L, Lindegaard JC, Kallehauge JF, Tanderup K, Pedersen EM. Diffusion Weighted MRI (DWI) for brachytherapy in locally advanced cervical cancer – determining the degree of distortion at 1.5T and 3T MRI. IFMBE Proceedings 34, pp. 172-175, 2011.

155. Ottosson RO, Behrens CF CTC-ask: a new algorithm for conversion of CT numbers to tissue parameters for Monte Carlo dose calculations applying DICOM RS knowledge. Phys Med Biol. 2011 Oct 25;56(22):N263-N274.

154. Noe KØ, Tanderup K, Sørensen TS Surface membrane based bladder registration for evaluation of accumulated dose during brachytherapy in cervical cancer IEEE International Symposium on Biomedical Imaging (ISBI) 2011. 4 pp. 1253-1256.

153. Appelt AL, Vogelius IR. A method to adjust radiation dose-response relationships for clinical risk factors. Radiother Oncol. 2011 Oct 6.

152. Toustrup K, Sørensen BS, Lassen P, Wiuf C, Alsner J, Overgaard J; On behalf of the Danish Head and Neck Cancer Group (DAHANCA). Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck Radiother Oncol. 2011 Oct 11.

151. Kertzscher G , Andersen CE , Siebert F-A , Nielsen SK ,Lindegaard JC, Tanderup K Identifying afterloading PDR and HDR brachytherapy errors using real-time fiber-coupled Al2O3:C dosimetry and a novel statistical error decision criterion Radiother Oncol. 2011 Sep;100(3):456-62.

150. Yates ES, Balling P, Petersen JB, Christensen MN, Skyt PS, Bassler N, Kaiser FJ, Muren LP. Characterization of the optical properties and stability of Presage™ following irradiation with photons and carbon ions. Acta Oncol. 2011 Aug;50(6):829-34.

149. Lassen-Ramshad Y, Vestergaard A, Muren LP, Høyer M, Petersen JB. Plan robustness in proton beam therapy of a childhood brain tumour. Acta Oncol. 2011 Aug;50(6):791-6.

148. Kaiser FJ, Bassler N, Tölli H, and Jäkel O Liquid ionization chambers for LET determination Radiation Measurements 45 (2010) 1109-1111.

147. Andersen CE, Damkjær SMS, Kertzscher G, Greilich S, and Aznar MC Fiber-coupled radioluminescence dosimetry with saturated Al2O3:C crystals: Characterization in 6 and 18 MV photon beams Radiation Measurements 46 (2011) 1090-1098

146. Kertzscher G, Andersen CE, Edmund JM, and Tanderup K Stem signal suppression in fiber-coupled Al2O3:C dosimetry for 192 Ir brachytherapy Radiation Measurements 2011

145. Lühr A, Toftegaard J, Kantemiris I, Hansen DC, Bassler N. Stopping power for particle therapy: The generic library libdEdx and clinically relevant stopping-power ratios for light ions. Int J Radiat Biol. 2011 Jul 19.

144. Hansen DC, Lühr A, Herrmann R, Sobolevsky N, Bassler N. Recent improvements in the SHIELD-HIT code. Int J Radiat Biol. 2011 Sep 7.

143. Havelund BM, Sørensen FB, Lindebjerg J, Spindler KL, Jakobsen A. Pretreatment HIF-1α and GLUT-1 expressions do not correlate with outcome after preoperative chemoradiotherapy in rectal cancer. Anticancer Res. 2011 May;31(5):1559-65.

142. Gonzalez-Angulo AM, Hennessy BT, Meric-Bernstam F, Sahin A, Liu W, Ju Z, Carey MS, Myhre S, Speers C, Deng L, Broaddus R, Lluch A, Aparicio S, Brown P, Pusztai L, Symmans WF, Alsner J, Overgaard J, Borresen-Dale AL, Hortobagyi GN, Coombes KR, Mills GB. Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer. Clin Proteomics. 2011 Jul 8;8(1):11.

141. Fokdal L, Tanderup K, Nielsen SK, Christensen HK, Røhl L, Pedersen EM, Schønemann NK, Lindegaard JC. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept. Radiother Oncol. 2011 Sep;100(3):473-9.

140. Offersen B, Højris I, Overgaard M. Radiation-induced heart morbidity after adjuvant radiotherapy of early breast cancer - Is it still an issue? Radiother Oncol. 2011 Aug;100(2):157-9.

139. Thor M, Petersen JB, Bentzen L, Høyer M, Muren LP. Deformable image registration for contour propagation from CT to cone-beam CT scans in radiotherapy of prostate cancer. Acta Oncol. 2011 Aug;50(6):918-25.

138. Thörnqvist S, Bentzen L, Petersen JB, Hysing LB, Muren LP. Plan robustness of simultaneous integrated boost radiotherapy of prostate and lymph nodes for different image-guidance and delivery techniques. Acta Oncol. 2011 Aug;50(6):926-34.

137. Skyt PS, Balling P, Petersen JB, Yates ES, Muren LP. Temperature dependence of the dose response for a solid-state radiochromic dosimeter during irradiation and storage Med Phys. 2011 May;38(5):2806-11

136. Bertelsen A, Schytte T, Bentzen SM, Hansen O, Nielsen M, Brink C. Radiation dose response of normal lung assessed by Cone Beam CT - A potential tool for biologically adaptive radiation therapy Radiother Oncol. 2011 Sep;100(3):351-5.

135. Bertelsen A, Lorenzen EL, and Brink C Validation of a new control system for Elekta accelerators facilitating continuously variable dose rate Med Phys. 2011 Aug;38(8):4802-10.

134. Ravkilde T, Keall PJ, Højbjerre K, Fledelius W, Worm E, Poulsen PR. Geometric accuracy of dynamic MLC tracking with an implantable wired electromagnetic transponder. Acta Oncol. 2011 Aug;50(6):944-51.

133. Nyeng TB, Kallehauge JF, Høyer M, Petersen JB, Poulsen PR, Muren LP. Clinical validation of a 4D-CT based method for lung ventilation measurement in phantoms and patients. Acta Oncol. 2011 Aug;50(6):897-907.

132. Rylander S, Thörnqvist S, Haack S, Pedersen EM, Muren LP. Intensity profile based measurement of prostate gold markers influence on 1.5 and 3T diffusion-weighted MR images. Acta Oncol. 2011 Aug;50(6):866-72.

131. Fledelius W, Keall PJ, Cho B, Yang X, Morf D, Scheib S, Poulsen PR. Tracking latency in image-based dynamic MLC tracking with direct image access. Acta Oncol. 2011 Aug;50(6):952-9.

130. Baker M, Nielsen M, Hansen O, Jahn JW, Korreman S, Brink C. Isotoxic Dose Escalation in the Treatment of Lung Cancer by Means of Heterogeneous Dose Distributions in the Presence of Respiratory Motion. Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):849-55.

129. Andreassen CN Searching for genetic determinants of normal tissue radiosensitivity--are we on the right track? Radiother Oncol. 2010 Oct;97(1):1-8.

128. Agarwal R, Gonzalez-Angulo AM, Myhre S, Carey M, Lee JS, Overgaard J, Alsner J, Stemke-Hale K, Lluch A, Neve RM, Kuo WL, Sorlie T, Sahin A, Valero V, Keyomarsi K, Gray JW, Borresen-Dale AL, Mills GB, Hennessy BT. Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer Clin Cancer Res. 2009 Jun 1;15(11):3654-62.

127. Poulsen PR, Carl J, Nielsen J, Nielsen MS, Thomsen JB, Jensen HK, Kjærgaard B, Zepernick PR, Worm E, Fledelius W, Cho B, Sawant A, Ruan D, Keall PJ. Megavoltage Image-Based Dynamic Multileaf Collimator Tracking of a NiTi Stent in Porcine Lungs on a Linear Accelerator Int J Radiat Oncol Biol Phys. 2011 May 21.

126. Toustrup K, Sørensen BS, Nordsmark M, Busk M, Wiuf C, Alsner J, Overgaard J. Development of a Hypoxia Gene Expression Classifier with Predictive Impact for Hypoxic Modification of Radiotherapy in Head and Neck Cancer Cancer Res. 2011 Sep 1;71(17):5923-31.

125. Brodin NP, Rosenschöld PM, Aznar MC, Kiil-Berthelsen A, Vogelius IR, Nilsson P, Lannering B, Björk-Eriksson T. Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma Acta Oncol. 2011 Aug;50(6):806-16.

124. Boejen A, Grau C. Virtual reality in radiation therapy training Surgical Oncology 20 (2011) 185-188

123. Vogelius IR, Westerly DC, Aznar MC, Cannon GM, Korreman SS, Mackie TR, Mehta MP, Bentzen SM. Estimated radiation pneumonitis risk after photon versus proton therapy alone or combined with chemotherapy for lung cancer Acta Oncol. 2011 Aug;50(6):772-6.

122. D'Andrea FP, Safwat A, Kassem M, Gautier L, Overgaard J, Horsman MR. Cancer stem cell overexpression of nicotinamide N-methyltransferase enhances cellular radiation resistance Radiother Oncol. 2011 Jun;99(3):373-8.

121. Mortensen LS, Busk M, Nordsmark M, Jakobsen S, Theil J, Overgaard J, Horsman MR. Accessing radiation response using hypoxia PET imaging and oxygen sensitive electrodes: A preclinical study Radiother Oncol. 2011 Jun;99(3):418-23.

120. Sørensen BS, Vestergaard A, Overgaard J, Præstegaard LH. Dependence of cell survival on instantaneous dose rate of a linear accelerator Radiother Oncol. 2011 Jul 5.

119. Christensen BO, Overgaard J, Kettner LO, Damsgaard TE. Long-term evaluation of postmastectomy breast reconstruction Acta Oncol. 2011 Oct;50(7):1053-61.

118. Sørensen BS, Overgaard J, Bassler N. In vitro RBE-LET dependence for multiple particle types Acta Oncol. 2011 Aug;50(6):757-62.

117. Hoff CM, Lassen P, Eriksen JG, Hansen HS, Specht L, Overgaard M, Grau C, Johansen J, Bentzen J, Andersen L, Evensen JF, Overgaard J. Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? - Results from the randomized DAHANCA 5 and 7 trials Acta Oncol. 2011 Oct;50(7):1006-14.

116. Elstrøm UV, Muren LP, Petersen JB, Grau C. Evaluation of image quality for different kV cone-beam CT acquisition and reconstruction methods in the head and neck region Acta Oncol. 2011 Aug;50(6):908-17.

115. Petersen JB, Lassen Y, Hansen AT, Muren LP, Grau C, Høyer M. Normal liver tissue sparing by intensity-modulated proton stereotactic body radiotherapy for solitary liver tumours Acta Oncol. 2011 Aug;50(6):823-8.

114. Hennessy BT, Lu Y, Gonzalez-Angulo AM, Carey MS, Myhre S, Ju Z, Davies MA, Liu W, Coombes K, Meric-Bernstam F, Bedrosian I, McGahren M, Agarwal R, Zhang F, Overgaard J, Alsner J, Neve RM, Kuo WL, Gray JW, Borresen-Dale AL, Mills GB. A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers Clin Proteomics. 2010 Dec;6(4):129-151.

113. Busk M, Walenta S, Mueller-Klieser W, Steiniche T, Jakobsen S, Horsman MR, Overgaard J. Inhibition of tumor lactate oxidation: Consequences for the tumor microenvironment. Radiother Oncol. 2011 Jun;99(3):404-11.

112. Vogelius IR, Bentzen SM, Maraldo MV, Petersen PM, Specht L. Risk factors for radiation-induced hypothyroidism: A Literature-Based Meta-Analysis. Cancer. 2011 May 12.

111. Aarup LR, Nahum AE, Zacharatou C, Juhler-Nøttrup T, Knöös T, Nyström H, Specht L, Wieslander E, Korreman SS. The effect of different lung densities on the accuracy of various radiotherapy dose calculation methods: implications for tumour coverage. Radiother Oncol. 2009 Jun;91(3):405-14.

110. Myhre S, Mohammed H, Tramm T, Alsner J, Finak G, Park M, Overgaard J, Børresen-Dale AL, Frigessi A, Sørlie T. In silico ascription of gene expression differences to tumor and stromal cells in a model to study impact on breast cancer outcome. PLoS One. 2010 Nov 19;5(11):e14002.

109. Ceberg S, Gagne I, Gustafsson H, Scherman JB, Korreman SS, Kjaer-Kristoffersen F, Hilts M, Bäck SA RapidArc treatment verification in 3D using polymer gel dosimetry and Monte Carlo simulation Phys Med Biol. 2010 Sep 7;55(17):4885-98.

108. Fredh A, Korreman S, Rosenschöld PM. Automated analysis of images acquired with electronic portal imaging device during delivery of quality assurance plans for inversely optimized arc therapy Radiother Oncol. 2010 Feb;94(2):195-8.

107. Logadóttir Á, Korreman S, Petersen PM. Comparison of the accuracy and precision of prostate localization with 2D-2D and 3D images. Radiother Oncol. 2011 Feb;98(2):175-80.

106. Vogelius IS, Westerly DC, Cannon GM, Mackie TR, Mehta MP, Sugie C, Bentzen SM. Intensity-Modulated Radiotherapy Might Increase Pneumonitis Risk Relative to Three-Dimensional Conformal Radiotherapy in Patients Receiving Combined Chemotherapy and Radiotherapy: A Modeling Study of Dose Dumping Int J Radiat Oncol Biol Phys. 2011 Jul 1;80(3):893-9.

105. Per Rugaard Poulsen, Walther Fledelius, Paul J. Keall, Elisabeth Weiss, Jun Lu, Emily Brackbill, and Geoffrey D. Hugo A method for robust segmentation of arbitrarily shaped radiopaque structures in cone-beam CT projections Med Phys. 2011 Apr;38(4):2151-6.

104. Poulsen PR, Cho B, Keall PJ. Real-time prostate trajectory estimation with a single imager in arc radiotherapy: a simulation study. Phys Med Biol. 2009 Jul 7;54(13):4019-35.

103. Poulsen PR, Cho B, Keall PJ Prediction of position estimation errors for 3D target trajectories estimated from cone-beam CT projections Proceedings of XVIth ICCR, Amsterdam 2010

102. Aznar MC, Korreman SS, Pedersen AN, Persson GF, Josipovic M, Specht L. Evaluation of dose to cardiac structures during breast irradiation. Br J Radiol. 2010 Dec 15.

101. Jørgensen MK, Hoffmann L, Petersen JB, Praestegaard LH, Hansen R, Muren LP. Tolerance levels of EPID-based quality control for volumetric modulated arc therapy Med Phys. 2011 Mar;38(3):1425-34.

100. Hansen AE, McEvoy F, Engelholm SA, Law I, Kristensen AT. FDG PET/CT imaging in canine cancer patients Vet Radiol Ultrasound. 2011 Mar-Apr;52(2):201-6.

99. Hansen AE, Kristensen AT, Law I, Jørgensen JT, Engelholm SA. Hypoxia-inducible factors--regulation, role and comparative aspects in tumourigenesis Vet Comp Oncol. 2011 Mar;9(1):16-37.

98. Lühr A, Hansen DC, Jäkel O, Sobolevsky N, Bassler N. Analytical expressions for water-to-air stopping-power ratios relevant for accurate dosimetry in particle therapy Phys Med Biol. 2011 Apr 21;56(8):2515-33.

97. Beierholm AR, Ottosson RO, Lindvold LR, Behrens CF, Andersen CE. Characterizing a pulse-resolved dosimetry system for complex radiotherapy beams using organic scintillators Phys Med Biol. 2011 May 21;56(10):3033-45.

96. Nielsen TB, Wieslander E, Fogliata A, Nielsen M, Hansen O, and Brink C. Influence of dose calculation algorithms on the predicted dose distributions and NTCP values for NSCLC patients Med Phys. 2011 May;38(5):2412-8.

95. Overgaard J. Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck - A systematic review and meta-analysis Radiother Oncol. 2011 Apr 19.

94. Fog LS, Rasmussen JF, Aznar M, Kjær-Kristoffersen F, Vogelius IR, Engelholm SA, Bangsgaard JP. A closer look at RapidArc® radiosurgery plans using very small fields Phys Med Biol. 2011 Mar 21;56(6):1853-63.

93. Lassen P, Eriksen JG, Krogdahl A, Therkildsen MH, Ulhøi BP, Overgaard M, Specht L, Andersen E, Johansen J, Andersen LJ, Grau C, Overgaard J The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: Evaluation of the randomised DAHANCA 6&7 trial. Radiother Oncol. 2011 Mar 21.

92. Wojdacz TK, Møller TH, Thestrup BB, Kristensen LS, Hansen LL. Limitations and advantages of MS-HRM and bisulfite sequencing for single locus methylation studies Expert Rev Mol Diagn. 2010 Jul;10(5):575-80.

91. Horsman MR, Bohn AB, Busk M. Vascular targeting therapy: potential benefit depends on tumor and host related effects Exp Oncol. 2010 Sep;32(3):143-8.

90. Hokland SL, Nielsen T, Busk M, Horsman MR. Imaging tumour physiology and vasculature to predict and assess response to heat Int J Hyperthermia. 2010;26(3):264-72.

89. Poulsen PR, Cho B, Sawant A, Keall PJ. Implementation of a new method for dynamic multileaf collimator tracking of prostate motion in arc radiotherapy using a single kV imager Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):914-23

88. Poulsen PR, Cho B, Ruan D, Sawant A, Keall PJ Dynamic multileaf collimator tracking of respiratory target motion based on a single kilovoltage imager during arc radiotherapy Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):600-7

87. Poulsen PR, Cho B, Sawant A, Ruan D, Keall PJ Detailed analysis of latencies in image-based dynamic MLC tracking Med Phys. 2010 Sep;37(9):4998-5005.

86. Herrmann R, Jäkel O, Palmans H, Sharpe P, Bassler N Dose response of alanine detectors irradiated with carbon ion beams Med Phys. 2011 Apr;38(4):1859-66.

85. Maeda Y, Høyer M, Lundby L, Buntzen S, Laurberg S. Temporary sacral nerve stimulation for faecal incontinence following pelvic radiotherapy Radiother Oncol. 2010 Oct;97(1):108-12

84. Greilich S, Grzanka L, Bassler N, Andersen CE, and Jäkel O. Amorphous track models: a numerical comparison study Radiation Measurements. 45, 10, p1406-09.

83. Pedersen K, Wiechec E, Madsen BE, Overgaard J, Hansen LL. A simple way to evaluate self-designed probes for tumor specific Multiplex Ligation-dependent Probe Amplification (MLPA) BMC Res Notes. 2010 Jun 26;3:179

82. Busk M, Toustrup K, Soerensen BS, Alsner J, Horsman MR, Jakobsen S, Overgaard J. In vivo Identification and Specificity assessment of mRNA markers of hypoxia in human and mouse tumors BMC Cancer. 2011 Feb 9;11(1):63.

81. Sørensen TS, Noe KØ, Christoffersen C, Kristiansen M, Mouridsen K, Østerby O, Brix L. Active Contours in Optical Flow Fields for Image Sequence Segmentation. IEEE International Symposium on Biomedical Imaging (ISBI) 2010 pp. 916-919.

80. Nygaard DE, Persson GF, Munck af Rosenschöld P, Specht L, Roed AP, Korreman SS. Evaluation of a semi-automatic and a manual visual method for selecting the midventilation bin in 4DCT scans of lung cancer patients. ICCR proceedings, 2010 (in press)

79. Maeda Y, Høyer M, Lundby L, Norton C. Faecal incontinence following radiotherapy for prostate cancer: A systematic review. Radiother Oncol. 2011 Feb;98(2):145-53.

78. Carl J, Nielsen J, Holmberg M, Larsen EH, Fabrin K, Fisker RV Clinical results from first use of prostate stent as fiducial for radiotherapy of prostate cancer. Acta Oncol. 2011 May;50(4):547-54.

77. Aznar MC, Petersen PM, Logadottir A, Lindberg H, Korreman SS, Kjær-Kristoffersen F, Engelholm SA. Rotational radiotherapy for prostate cancer in clinical practice Radiother Oncol. 2010 Dec;97(3):480-4

76. Persson GF, Nygaard DE, af Rosenschöld PM, Vogelius IR, Josipovic M, Specht L, Korreman SS. Artifacts in conventional computed tomography (CT) and free breathing four-dimensional CT induce uncertainty in gross tumor volume determination Int J Radiat Oncol Biol Phys. 2010 Dec 14.

75. Skyt PS, Balling P, Petersen JB, Yates ES, and Muren LP. Effect of irradiation and storage temperature on PRESAGE™ dose response Journal of Physics:Conference Series 250 (2010)

74. Wiechec E, Wiuf C, Overgaard J, Hansen LL. High Resolution Melting (HRM) analysis for mutation screening of RGSL1, RGS16 and RGS8 in breast cancer Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):397-407.

73. Waldeland E, Helt-Hansen J, Malinen E. Characterization of lithium formate EPR dosimeters for high dose applications - Comparison with alanine Radiation Measurements. Volume 46, Issue 2, February 2011, Pages 213-218

72. West C, Rosenstein BS, Alsner J, Azria D, Barnett G, Begg A, Bentzen S, Burnet N, Chang-Claude J, Chuang E, Coles C, De Ruyck K, De Ruysscher D, Dunning A, Elliott R, Fachal L, Hall J, Haustermans K, Herskind C, Hoelscher T, Imai T, Iwakawa M, Jones D, Kulich C; EQUAL-ESTRO, Langendijk JH, O'Neils P, Ozsahin M, Parliament M, Polanski A, Rosenstein B, Seminara D, Symonds P, Talbot C, Thierens H, Vega A, West C, Yarnold J Establishment of a Radiogenomics Consortium Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1295-6

71. Vestergaard A, Søndergaard J, Petersen JB, Høyer M, Muren LP A comparison of three different adaptive strategies in image-guided radiotherapy of bladder cancer Acta Oncol. 2010 Oct;49(7):1069-76

70. Ottosson W, Baker M, Hedman M, Behrens CF, Sjöström D. Evaluation of setup accuracy for NSCLC patients; studying the impact of different types of cone-beam CT matches based on whole thorax, columna vertebralis, and GTV Acta Oncol. 2010 Oct;49(7):1184-91.

69. Petit SF, Dekker AL, Seigneuric R, Murrer L, van Riel NA, Nordsmark M, Overgaard J, Lambin P, Wouters BG. Intra-voxel heterogeneity influences the dose prescription for dose-painting with radiotherapy: a modelling study Phys Med Biol. 2009 Apr 7;54(7):2179-96.

68. Offersen BV, Knap MM, Horsman MR, Verheijen J, Hanemaaijer R, Overgaard J. Matrix metalloproteinase-9 measured in urine from bladder cancer patients is an independent prognostic marker of poor survival Acta Oncol. 2010 Nov;49(8):1283-7

67. af Rosenschöld PM, Aznar MC, Nygaard DE, Persson GF, Korreman SS, Engelholm SA, Nyström H. A treatment planning study of the potential of geometrical tracking for intensity modulated proton therapy of lung cancer Acta Oncol. 2010 Oct;49(7):1141-8.

66. Lassen P. The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome Radiother Oncol. 2010 Jun;95(3):371-80

65. Knap MM, Hoffmann L, Nordsmark M, Vestergaard A. Daily cone-beam computed tomography used to determine tumour shrinkage and localisation in lung cancer patients Acta Oncol. 2010 Oct;49(7):1077-84

64. Kantemiris I, Angelopoulos A, Bassler N, Giokaris N, Holzscheiter MH, Karaiskos P, Kalogeropoulos TE; AD-4/ACE Collaboration. Real-time imaging for dose evaluation during antiproton irradiation Phys Med Biol. 2010 Mar 7;55(5):N123-31

63. Hellebust TP, Kirisits C, Berger D, Pérez-Calatayud J, De Brabandere M, De Leeuw A, Dumas I, Hudej R, Lowe G, Wills R, Tanderup K; Gynaecological (GYN) GEC-ESTRO Working Group. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy Radiother Oncol. 2010 Aug;96(2):153-60

62. Bassler N. Radiation damage in charge-coupled devices Radiat Environ Biophys. 2010 Aug;49(3):373-8

61. Eriksen JG, Overgaard M. Late onset of skin toxicity induced by EGFr-inhibitors Radiother Oncol. 2009 Feb;90(2):280-1

60. Hoff CM, Hansen HS, Overgaard M, Grau C, Johansen J, Bentzen J, Overgaard J. The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy - Results from the randomized DAHANCA 5 study Radiother Oncol. 2011 Jan;98(1):28-33

59. Kaiser FJ, Bassler N, Jäkel O. COTS Silicon diodes as radiation detectors in proton and heavy charged particle radiotherapy 1. Radiat Environ Biophys. 2010 Aug;49(3):365-71.

58. Schmitz T, Blaickner M, Schütz C, Wiehl N, Kratz JV, Bassler N, Holzscheiter MH, Palmans H, Sharpe P, Otto G, Hampel G. Dose calculation in biological samples in a mixed neutron-gamma field at the TRIGA reactor of the University of Mainz. Acta Oncol. 2010 Oct;49(7):1165-9

57. Fenkell L, Assenholt M, Nielsen SK, Haie-Meder C, Pötter R, Lindegaard J, Tanderup K. Parametrial Boost Using Midline Shielding Results in an Unpredictable Dose to Tumor and Organs at Risk in Combined External Beam Radiotherapy and Brachytherapy for Locally Advanced Cervical Cancer. Int J Radiat Oncol Biol Phys. 2010 Aug 26.

56. Tanderup K, Pötter R, Lindegaard JC, Berger D, Wambersie A, Kirisits C PTV margins should not be used to compensate for uncertainties in 3D image guided intracavitary brachytherapy Radiother Oncol. 2010 Dec;97(3):495-500.

55. Partridge M, Yamamoto T, Grau C, Høyer M, Muren LP Imaging of normal lung, liver and parotid gland function for radiotherapy Acta Oncol. 2010 Oct;49(7):997-1011

54. Nawroth I, Alsner J, Behlke MA, Besenbacher F, Overgaard J, Howard KA, Kjems J Intraperitoneal administration of chitosan/DsiRNA nanoparticles targeting TNFα prevents radiation-induced fibrosis Radiother Oncol. 2010 Oct;97(1):143-8.

53. Korreman SS, Ulrich S, Bowen S, Deveau M, Bentzen SM, Jeraj R. Feasibility of dose painting using volumetric modulated arc optimization and delivery. Acta Oncol. 2010 Oct;49(7):964-71.

52. Due AK, Korreman S, Bentzen SM, Tomé W, Bender E, Aznar M, Vogelius I, Berthelsen AK, Kristensen CA, Specht L. Methodologies for localizing loco-regional hypopharyngeal carcinoma recurrences in relation to FDG-PET positive and clinical radiation therapy target volumes. Acta Oncol. 2010 Oct;49(7):984-90.

51. Vogelius IS, Westerly DC, Cannon GM, Bentzen SM. Hypofractionation does not increase radiation pneumonitis risk with modern conformal radiation delivery techniques. Acta Oncol. 2010 Oct;49(7):1052-7.

50. Grau C, Olsen DR, Overgaard J, Høyer M, Lindegaard JC, Muren LP. Biology-guided adaptive radiation therapy - presence or future? Acta Oncol. 2010 Oct;49(7):884-7.

49. Nielsen T, Murata R, Maxwell RJ, Stødkilde-Jørgensen H, Ostergaard L, Ley CD, Kristjansen PE, Horsman MR. Non-invasive imaging of combretastatin activity in two tumor models: Association with invasive estimates. Acta Oncol. 2010 Oct;49(7):906-13.

48. Busk M, Munk OL, Jakobsen S, Wang T, Skals M, Steiniche T, Horsman MR, Overgaard J. Assessing hypoxia in animal tumor models based on pharmocokinetic analysis of dynamic FAZA PET. Acta Oncol. 2010 Oct;49(7):922-33.

47. Mortensen LS, Buus S, Nordsmark M, Bentzen L, Munk OL, Keiding S, Overgaard J. Identifying hypoxia in human tumors: A correlation study between (18)F-FMISO PET and the Eppendorf oxygen-sensitive electrode. Acta Oncol. 2010 Oct;49(7):934-40.

46. Haack S, Pedersen EM, Jespersen SN, Kallehauge JF, Lindegaard JC, Tanderup K. Apparent diffusion coefficients in GEC ESTRO target volumes for image guided adaptive brachytherapy of locally advanced cervical cancer. Acta Oncol. 2010 Oct;49(7):978-83.

45. Kallehauge JF, Tanderup K, Haack S, Nielsen T, Muren LP, Fokdal L, Lindegaard JC, Pedersen EM. Apparent Diffusion Coefficient (ADC) as a quantitative parameter in diffusion weighted MR imaging in gynecologic cancer: Dependence on b-values used. Acta Oncol. 2010 Oct;49(7):1017-22.

44. Thörnqvist S, Petersen JB, Høyer M, Bentzen LN, Muren LP. Propagation of target and organ at risk contours in radiotherapy of prostate cancer using deformable image registration. Acta Oncol. 2010 Oct;49(7):1023-32.

43. Wright P, Muren LP, Høyer M, Malinen E. Evaluation of adaptive radiotherapy of bladder cancer by image-based tumour control probability modelling. Acta Oncol. 2010 Oct;49(7):1045-51.

42. Thor M, Væth M, Karlsdottir A, Muren LP. Rectum motion and morbidity prediction: Improving correlation between late morbidity and DVH parameters through use of rectum planning organ at risk volumes. Acta Oncol. 2010 Oct;49(7):1061-8.

41. Poulsen PR, Cho B, Sawant A, Ruan D, Keall PJ. Dynamic MLC tracking of moving targets with a single kV imager for 3D conformal and IMRT treatments. Acta Oncol. 2010 Oct;49(7):1092-100.

40. Elstrøm UV, Wysocka BA, Muren LP, Petersen JB, Grau C. Daily kV cone-beam CT and deformable image registration as a method for studying dosimetric consequences of anatomic changes in adaptive IMRT of head and neck cancer. Acta Oncol. 2010 Oct;49(7):1101-8.

39. Herrmann R, Carl J, Jäkel O, Bassler N, Petersen JB. Investigation of the dosimetric impact of a Ni-Ti fiducial marker in carbon ion and proton beams. Acta Oncol. 2010 Oct;49(7):1160-4.

38. Schytte T, Hansen O, Stolberg-Rohr T, Brink C. Cardiac toxicity and radiation dose to the heart in definitive treated non-small cell lung cancer. Acta Oncol. 2010 Oct;49(7):1058-60

37. Gottlieb KL, Hansen CR, Hansen O, Westberg J, Brink C. Investigation of respiration induced intra- and inter-fractional tumour motion using a standard Cone Beam CT Acta Oncol. 2010 Oct;49(7):1192-8

36. Worm ES, Hansen AT, Petersen JB, Muren LP, Præstegaard LH, Høyer M. Inter- and intrafractional localisation errors in cone-beam CT guided stereotactic radiation therapy of tumours in the liver and lung Acta Oncol. 2010 Oct;49(7):1177-83.

35. Persson GF, Nygaard DE, Brink C, Jahn JW, Munck af Rosenschöld P, Specht L, Korreman SS. Deviations in delineated GTV caused by artefacts in 4DCT Radiother Oncol. 2010 Jul;96(1):61-6

34. Eriksen JG, Lassen P, Overgaard J. Do all patients with head and neck cancer benefit from radiotherapy and concurrent cetuximab? Lancet Oncol. 2010 Apr;11(4):312-3.

33. Ottosson RO, Karlsson A, Behrens CF Pareto front analysis of 6 and 15 MV dynamic IMRT for lung cancer using pencil beam, AAA and Monte Carlo Phys Med Biol. 2010 Aug 21;55(16):4521-33

32. Carl J, Jensen HK, Nielsen J, Nielsen MS, Schmid M, Loeschke S Bronchoscopic insertion and removal of a new fiducial Nine Ten stent fields in the Göttingen mini-pig lung: A feasibility study-I. In press

31. Buhl SK, Duun-Christensen AK, Kristensen BH, Behrens CF Clinical evaluation of 3D/3D MRI-CBCT automatching on brain tumors for online patient setup verification – A step towards MRI-based treatment planning Acta Oncol. 2010 Oct;49(7):1085-91.

30. Bassler N, Holzscheiter M Calculated LET Spectrum from Antiproton Beams Stopping in Water Acta Oncol. 48: 223-226, 2009.

29. Bassler N, Jäkel O, Søndergaard CS, Petersen JB Dose-and LET-painting with particle therapy Acta Oncol. 2010 Oct;49(7):1170-6.

28. Bassler N, Holzscheiter MH, Petersen JB Neutron Fluence in Antiproton Radiotherapy, Measurements and Simulations Acta Oncol. 2010 Oct;49(7):1149-59.

27. Jensen I, Carl J, Lund B, Larsen EH, Nielsen J. Radiobiological impact of reduced margins and treatment technique for prostate cancer in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP). Med Dosim. 2010 May 18

26. Søndergaard J, Olsen KO, Muren LP, Elstrøm UV, Grau C, Høyer M A study of image-guided radiotherapy of bladder cancer based on lipiodol injection in the bladder wall Acta Oncol. 2010 Oct;49(7):1109-15

25. Sørensen BS, Toustrup K, Horsman MR, Overgaard J, Alsner J Identifying pH independent hypoxia induced genes in human squamous cell carcinomas in vitro Acta Oncol. 2010 Oct;49(7):895-905.

24. Olsen DR, Overgaard J Leveraging clinical performance by technological excellence - The case of particle therapy Radiother Oncol. 2010 Apr;95(1):1-2

23. K. Ø. Noe, T.S. Sørensen Solid Mesh Registration for Radiotherapy Treatment Planning Lecture Notes in Computer Science 2010; volume 5958 pp. 59-70

22. Tanderup K, Georg D, Pötter R, Kirisits C, Grau C, Lindegaard JC. Adaptive management of cervical cancer radiotherapy Semin Radiat Oncol. 2010 Apr;20(2):121-9

21. Overgaard J, Mohanti BK, Begum N, Ali R, Agarwal JP, Kuddu M, Bhasker S, Tatsuzaki H, Grau C. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial Lancet Oncol. 2010 Jun;11(6):553-60

20. Bertelsen A, Hansen CR, Johansen J, Brink C Single Arc Volumetric Modulated Arc Therapy of head and neck cancer Radiother Oncol. 2010 May;95(2):142-8

19. Bassler N, Kantemiris I, Karaiskos P, Engelke J, Holzscheiter MH, Petersen JB. Comparison of optimized single and multifield irradiation plans of antiproton, proton and carbon ion beams Radiother Oncol. 2010 Apr;95(1):87-93

18. Tanderup K, Nielsen SK, Nyvang GB, Pedersen EM, Røhl L, Aagaard T, Fokdal L, Lindegaard JC. From point A to the sculpted pear: MR image guidance significantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer Radiother Oncol. 2010 Feb;94(2):173-80

17. Westberg J, Jensen HR, Bertelsen A, Brink C Reduction of Cone-Beam CT scan time without compromising the accuracy of the image registration in IGRT Acta Oncol. 2010;49(2):225-9

16. Falk M, Af Rosenschöld PM, Keall P, Cattell H, Cho BC, Poulsen P, Povzner S, Sawant A, Zimmerman J, Korreman S. Real-time dynamic MLC tracking for inversely optimized arc radiotherapy Radiother Oncol. 2010 Feb;94(2):218-23

15. Karlsdottir A, Muren LP, Wentzel-Larsen T, Johannessen DC, Haukaas SA, Halvorsen OJ, Dahl O Outcome in intermediate or high risk prostate cancer patients receiving radiation dose and hormone therapy Acta Oncol. 2009;48(6):874-81

14. Kopek N, Holt MI, Hansen AT, Høyer M Stereotactic body radiotherapy for unresectable cholangiocarcinoma Radiother Oncol. 2010 Jan;94(1):47-52

13. Andersen CE, Nielsen SK, Lindegaard JC, Tanderup K Time-resolved in vivo luminescence dosimetry for online error detection in pulsed dose-rate brachytherapy Med Phys. 2009 Nov;36(11):5033-43

12. Wright P, Redpath AT, Høyer M, Muren LP A method to individualize adaptive planning target volumes for deformable targets Phys Med Biol. 2009 Dec 7;54(23):7121-7133.

11. Lassen P, Eriksen JG, Hamilton-Dutoit S, Tramm T, Alsner J, Overgaard J; HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer Radiother Oncol. 2010 Jan;94(1):30-5

10. Overgaard J. Chemoradiotherapy of head and neck cancer – Can the bumble bee fly? Radiother Oncol. 2009 Jul;92(1):1-3.

9. Kopek N, Paludan M, Petersen J, Hansen AT, Grau C, Høyer M. Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer Radiother Oncol. 2009 Dec;93(3):402-7

8. Busk M, Horsman MR, Jakobsen S, Hansen KV, Bussink J, van der Kogel A, Overgaard J. Can hypoxia-PET map hypoxic cell density heterogeneity accurately in an animal tumor model at a clinically obtainable image contrast? Radiother Oncol. 2009 Sep;92(3):429-36.

7. Andreassen CN, Alsner J Genetic variants and normal tissue toxicity after radiotherapy: A systematic review Radiother Oncol. 2009 Sep;92(3):299-309.

6. Sørensen BS, Horsman MR, Vorum H, Honoré B, Overgaard J, Alsner J Proteins upregulated by mild and severe hypoxia in squamous cell carcinomas in vitro identified by proteomics Radiother Oncol. 2009 Sep;92(3):443-9

5. Haack S, Nielsen SK, Lindegaard JC, Gelineck J, Tanderup K Applicator reconstruction in MRI 3D image-based dose planning of brachytherapy for cervical cancer Radiother Oncol. 2009 May;91(2):187-93.

4. Offersen BV, Overgaard M, Kroman N, Overgaard J Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review Radiother Oncol. 2009 Jan;90(1):1-13.

3. Lassen P, Eriksen JG, Hamilton-Dutoit S, Tramm T, Alsner J, Overgaard J Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck J Clin Oncol. 2009 Apr 20;27(12):1992-8.

2. Søndergaard J, Høyer M, Petersen JB, Wright P, Grau C, Muren LP The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy. Acta Oncol. 2009;48(2):238-44.

1. Andersen CE, Nielsen SK, Greilich S, Helt-Hansen J, Lindegaard JC, Tanderup K Characterization of a fiber-coupled Al2O3:C luminescence dosimetry system for online in vivo dose verification during 192Ir brachytherapy Med Phys. 2009 Mar;36(3):708-18.